British Patient Capital has committed €25m to Finch Capital’s Europe Fund III, which has reached a final close.
UK and Netherlands-based venture capital firm Finch Capital’s latest vehicle will target European fintech companies with high growth potential, and is British Patient Capital’s first commitment to a dedicated fintech fund. It will look to invest €2m-10m per company, acquiring significant minority stakes in scale-up businesses with €2m-10m in revenues. As with previous funds, Finch plans to back 15-20 European start-ups, targeting liquidity three to five years post-investment, over the fund’s three-year initial investment lifespan.
Catherine Lewis La Torre, CEO of British Patient Capital, said: “The UK has been a world-leader in financial services for decades and is now leading the fintech revolution. Fostering innovation across the UK, and supporting innovation-led businesses, is vital to empowering our economy. With fintech now accounting for around half of all technology deal flow in Europe, investing in Finch Capital’s Europe III fund provides a great opportunity to back companies leading in the sector. We are excited to work with Finch Capital as they continue to grow their presence in the UK and back the best UK and European growth stage fintech companies.”